219 related articles for article (PubMed ID: 9018119)
1. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells.
Takenaga K; Nakamura Y; Sakiyama S
Oncogene; 1997 Jan; 14(3):331-7. PubMed ID: 9018119
[TBL] [Abstract][Full Text] [Related]
2. Involvement of S100-related calcium-binding protein pEL98 (or mts1) in cell motility and tumor cell invasion.
Takenaga K; Nakamura Y; Endo H; Sakiyama S
Jpn J Cancer Res; 1994 Aug; 85(8):831-9. PubMed ID: 7928629
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
[TBL] [Abstract][Full Text] [Related]
4. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis.
Sherbet GV; Lakshmi MS
Anticancer Res; 1998; 18(4A):2415-21. PubMed ID: 9703888
[TBL] [Abstract][Full Text] [Related]
5. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.
Lloyd BH; Platt-Higgins A; Rudland PS; Barraclough R
Oncogene; 1998 Jul; 17(4):465-73. PubMed ID: 9696040
[TBL] [Abstract][Full Text] [Related]
6. The role of S100A4 gene encoding an S100-related calcium-binding protein in human bile duct adenocarcinoma cell lines: correlation of S100A4 expression and invasive growth in Matrigel Matrix.
Katayama N; Murao S; Ajiki T; Kitazawa S; Onoyama H; Kuroda Y; Maeda S
Int J Mol Med; 2000 Nov; 6(5):539-42. PubMed ID: 11029520
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional down-regulation of the metastasis-inducing S100A4 (p9Ka) in benign but not in malignant rat mammary epithelial cells by GC-factor.
Chen D; Davies MP; Rudland PS; Barraclough R
J Biol Chem; 1997 Aug; 272(32):20283-90. PubMed ID: 9242709
[TBL] [Abstract][Full Text] [Related]
8. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
[TBL] [Abstract][Full Text] [Related]
9. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Maelandsmo GM; Hovig E; Skrede M; Engebraaten O; Flørenes VA; Myklebost O; Grigorian M; Lukanidin E; Scanlon KJ; Fodstad O
Cancer Res; 1996 Dec; 56(23):5490-8. PubMed ID: 8968106
[TBL] [Abstract][Full Text] [Related]
10. Metastasis-associated protein S100A4: spotlight on its role in cell migration.
Tarabykina S; Griffiths TR; Tulchinsky E; Mellon JK; Bronstein IB; Kriajevska M
Curr Cancer Drug Targets; 2007 May; 7(3):217-28. PubMed ID: 17504119
[TBL] [Abstract][Full Text] [Related]
11. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
Shi Y; Zou M; Collison K; Baitei EY; Al-Makhalafi Z; Farid NR; Al-Mohanna FA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
[TBL] [Abstract][Full Text] [Related]
13. S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells.
Gao XN; Tang SQ; Zhang XF
J Pediatr Surg; 2005 Apr; 40(4):648-52. PubMed ID: 15852272
[TBL] [Abstract][Full Text] [Related]
14. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.
Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R
Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508
[TBL] [Abstract][Full Text] [Related]
15. Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes.
Wang G; Zhang S; Fernig DG; Martin-Fernandez M; Rudland PS; Barraclough R
Oncogene; 2005 Feb; 24(8):1445-54. PubMed ID: 15608682
[TBL] [Abstract][Full Text] [Related]
16. [The role of the mts1 gene in the metastatic process].
Grigorian MS; Zain S; Georgiev GP; Lukanidin EM
Dokl Akad Nauk; 1994 Feb; 334(6):788-90. PubMed ID: 8167601
[No Abstract] [Full Text] [Related]
17. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
[TBL] [Abstract][Full Text] [Related]
18. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
[TBL] [Abstract][Full Text] [Related]
20. Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1.
Wang G; Rudland PS; White MR; Barraclough R
J Biol Chem; 2000 Apr; 275(15):11141-6. PubMed ID: 10753920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
